Functional Architecture of the Inner Pore of a Voltage-gated Ca2+ Channel by Zhen, Xiao-guang et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
G
e
n
e
r
a
l
 
P
h
y
s
i
o
l
o
g
y
 
J. Gen. Physiol. © The Rockefeller University Press $8.00
Volume 126 Number 3 September 2005 193–204
http://www.jgp.org/cgi/doi/10.1085/jgp.200509292
 
193
 
ARTICLE
 
Functional Architecture of the Inner Pore of a Voltage-gated 
Ca
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The inner pore of voltage-gated Ca
 
2
 
 
 
 channels (VGCCs) is functionally important, but little is known about the
architecture of this region. In K
 
 
 
 channels, this part of the pore is formed by the S6/M2 transmembrane segments
from four symmetrically arranged subunits. The Ca
 
2
 
 
 
 channel pore, however, is formed by four asymmetric
domains of the same (
 
 
 
1
 
) subunit. Here we investigated the architecture of the inner pore of P/Q-type Ca
 
2
 
 
 
channels using the substituted-cysteine accessibility method. Many positions in the S6 segments of all four repeats
of the 
 
 
 
1
 
 subunit (Ca
 
v
 
2.1) were modiﬁed by internal methanethiosulfonate ethyltrimethylammonium (MTSET).
However, the pattern of modiﬁcation does not ﬁt any known sequence alignment with K
 
 
 
 channels. In IIS6, ﬁve
consecutive positions showed clear modiﬁcation, suggesting a likely aqueous crevice and a loose packing between
S6 and S5 segments, a notion further supported by the observation that some S5 positions were also accessible to
internal MTSET. These results indicate that the inner pore of VGCCs is indeed formed by the S6 segments but is
different from that of K
 
 
 
 channels. Interestingly some residues in IIIS6 and IVS6 whose mutations in L-type Ca
 
2
 
 
 
channels affect the binding of dihydropyridines and phenylalkylamines and are thought to face the pore appeared
not to react with internal MTSET. Probing with qBBr, a rigid thiol-reactive agent with a dimension of 12 Å 
 
 
 
 10 Å 
 
 
 
6 Å suggests that the inner pore can open to 
 
 
 
10 Å. This work provides an impetus for future studies on ion per-
meation, gating, and drug binding of VGCCs.
 
INTRODUCTION
 
Among the extended family of voltage-gated ion chan-
nels, VGCCs (voltage-gated Ca
 
2
 
 
 
 channels) are of
particular functional importance. Opening of these
channels not only changes the membrane potential,
but the resulting inﬂux of Ca
 
2
 
 
 
 ions also serves as a
second messenger, initiating diverse events such as
contraction, secretion, synaptic transmission, and gene
expression. Physiological and pharmacological studies
have identiﬁed multiple types of voltage-gated calcium
currents, including L, N, P/Q, R, and T. Biochemical
and molecular studies show that VGCCs are multimeric
complexes of several distinct subunits: 
 
 
 
1
 
, 
 
 
 
, 
 
 
 
2
 
 
 
, and
sometimes 
 
 
 
. The different types of Ca
 
2
 
 
 
 currents are
deﬁned by different 
 
 
 
1
 
 subunits (Catterall, 2000). As
the primary subunit, 
 
 
 
1
 
 is equipped with most functions
of the channel: it forms the ion conduction pore, incor-
porates the voltage sensor and gating apparatus, and
carries many sites for regulation by second messengers,
G proteins, protein kinases and phosphatases, agonists,
antagonists, and toxins. The topology of various 
 
 
 
1
 
subunits is the same, containing four homologous re-
peats, each consisting of six transmembrane segments
(S1–S6) and a pore loop (P-loop) between S5 and S6
(Fig. 1 A). The 
 
 
 
 and 
 
 
 
2
 
 
 
 subunits are auxiliary subunits
and regulate channel assembly, trafﬁcking, membrane
targeting, activation, and inactivation properties (Cat-
terall, 2000).
Previous structure–function studies on VGCCs show
that the P-loop, which harbors four conserved glu-
tamate residues, forms the ion selectivity ﬁlter and is
critical for Ca
 
2
 
 
 
 selectivity and permeation (Kim et al.,
1993; Tang et al., 1993; Yang et al., 1993; Ellinor et al.,
1995). The inner pore of VGCCs is also likely to be
important for Ca
 
2
 
 
 
 permeation as well as for gating, as
in K
 
 
 
 channels. It also harbors binding sites for organic
molecules such as phenylalkylamines (PAAs), ben-
zothiazepines (BTZs), and dihydropyridines (DHPs)
(Peterson et al., 1996, 1997; Hockerman et al., 1995,
1997a,b), which are commonly used drugs for the
treatment of cardiovascular diseases. In K
 
 
 
 channels,
the inner pore is formed by the S6/M2 transmembrane
segments from four symmetrically arranged subunits,
as revealed by site-directed chemical modiﬁcations and
x-ray crystallography (Liu et al., 1997; Doyle et al.,
1998; Lu et al., 1999a; Jiang et al., 2002a,b, 2003a,b). By
contrast, little is known about the architecture of the
inner pore of VGCCs, which are thought to be evolved
from K
 
 
 
 channels but their pore is formed by four
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asymmetric domains of the same (
 
 
 
1
 
) subunit. There is
yet no systematic analysis of which transmembrane re-
gions and amino acids form the inner pore of VGCCs.
In this study, we investigated the architecture of the
inner pore of P/Q-type (Ca
 
v
 
2.1) Ca
 
2
 
 
 
 channels using
the substituted-cysteine accessibility method (SCAM),
which has been used in various types of channels to
identify pore-lining residues, size the channel, examine
the conformational changes in different functional
states, and locate the activation gate (e.g., Akabas et al.,
1992, 1994; Yang and Horn, 1995; Liu et al., 1997; Lu et
al., 1999a,b; Liu and Siegelbaum, 2000; Wu et al., 2000;
del Camino and Yellen, 2001; Flynn and Zagotta, 2001;
Xiao et al., 2003; for review see Karlin and Akabas,
1998). We systematically mutated residues of all four S6
segments of the 
 
 
 
1
 
 subunit (Ca
 
v
 
2.1) to cysteines, one at
a time, and probed the mutant channel with a water-
soluble sulfhydryl-speciﬁc reagent, which forms a cova-
lent bond with the sulfhydryl group on the accessible
cysteine. Our results indicate that the inner pore of
VGCCs shares some properties with that of K
 
 
 
 channels
but also possesses certain unique and surprising fea-
tures. Thus, many positions in the S6 segments of all
four repeats were found to be modiﬁed by internal
methanethiosulfonate ethyltrimethylammonium (MT-
SET), indicating that the inner pore of VGCCs is in-
deed formed by S6. However, the pattern of modiﬁca-
tion does not ﬁt any known sequence alignment with
K
 
 
 
 channels and is consistent with an asymmetric archi-
tecture. In IIS6, ﬁve consecutive positions showed clear
modiﬁcation, suggesting a likely aqueous crevice be-
tween S6 and S5 segments, a notion further supported
by the observation that some S5 positions were also ac-
cessible to internal MTSET. This loose packing of the
S6 and S5 segments is different from the tight packing
in K
 
 
 
 channels. Finally, some residues in IIIS6 and IVS6
whose mutations in L-type (Ca
 
v
 
1.2) channels affect the
binding of DHPs and/or PAAs and are thought to face
the pore appeared not to react with internal MTSET.
 
MATERIALS AND METHODS
 
Molecular Biology
 
Ca
 
v
 
2.1 (GenBank/EMBL/DDBJ accession no. X57689) and 
 
 
 
2
 
 
 
(Mikami et al., 1989) cDNAs are from rabbit brain and skeletal
muscle, respectively. 
 
 
 
2a
 
 cDNA (M80545) is from rat brain. Site-
directed mutations were generated by either PCR mutagenesis or
the oligo nucleotide insertion method and were conﬁrmed by se-
quencing. Eight endogenous cysteines in the N terminus, intra-
cellular loops, IVS6, and C terminus of Ca
 
v
 
2.1 were mutated to
alanines. The channel formed by this mutant subunit and the 
 
 
 
2
 
 
 
and 
 
 
 
 subunits is called “the control channel.” All cysteine muta-
tions were made on this “control” 
 
 
 
1
 
 subunit. All 
 
 
 
1
 
 constructs
and 
 
 
 
2
 
 
 
 were cloned in an oocyte expression vector, pGEMHE,
or one of its variants. The 
 
 
 
2a
 
 subunit was cloned in the Blue-
script SK vector; it was chosen because it confers the slowest inac-
tivation, which greatly facilitates our experiments. cRNA for all
constructs were transcribed in vitro using the T7 polymerase.
 
Oocyte Expression
 
Ovarian lobes were obtained from adult 
 
Xenopus laevis
 
 under an-
esthesia. Stage V–VI oocytes were prepared by treatment with 2
mg/ml collagenase A (Roche) for 1.5–2.5 h under 200 rpm shak-
ing in a solution containing 82.4 mM NaCl, 2.5 mM KCl, 1 mM
MgCl
 
2
 
, and 5 mM HEPES (pH 7.6) and then rinsed twice (15
min each) with ND96 solution containing 96 mM NaCl, 2.5 mM
KCl, 1 mM MgCl
 
2
 
, 5 mM HEPES, 1.8 mM CaCl
 
2
 
, 100 U/ml peni-
cillin, and 100 
 
 
 
g/ml streptomycin (pH 7.6). The 
 
 
 
1
 
, 
 
 
 
2
 
 
 
, and
 
 
 
2a
 
 cRNA were injected into defoliculated oocytes with a total
concentration of 
 
 
 
0.5 
 
 
 
g/
 
 
 
l (ratio 
 
 
 
1
 
:
 
 
 
2
 
 
 
:
 
 
 
2a
 
 
 
 
 
 5:5:4) and a vol-
ume of 
 
 
 
50 nl per oocyte. Injected oocytes were maintained in
ND96 solution in an 18
 
 
 
C incubator, and used for recordings 3–6 d
after injection.
 
Electrophysiology
 
Whole-cell currents recorded with two-electrode voltage-clamp
with the OC-725C oocyte clamp ampliﬁer (Warner Instruments)
were used mainly for checking the functional expression of mu-
tant channels in oocytes. The recording electrodes were ﬁlled
with 3 M KCl and had resistances of 
 
 
 
0.5–1 M
 
 
 
. The bath solu-
tion contained 10 mM BaCl
 
2
 
, 5 mM KCl, 60 mM TEA-OH, 20 mM
NaOH, and 5 mM HEPES (pH 7.4 with methanesulphonic acid).
All patch-clamp recordings were performed using the inside-
out conﬁguration. Oocyte was bathed in a bath solution contain-
ing 125 mM KCl, 4 mM NaCl, 10 mM HEPES, 10 mM EGTA (pH
7.3 with KOH). The control solution, which in addition con-
tained 2 mM Mg-ATP and 3 
 
 
 
M sonicated PIP
 
2
 
, was prepared
fresh daily. Recording glass pipettes pulled from pyrex glass
tubes (Corning) were ﬁlled with a solution of 85 mM BaCl
 
2
 
, 10
mM HEPES (pH 7.3 with KOH), and had a resistance of 0.2–0.3
M
 
 
 
. When monovalent current was recorded, the pipettes were
ﬁlled with the bath solution. Control and test solutions (with the
reagent dissolved in the control solution) were fed by gravity
through separate tubes to a manifold attached to a single outlet
tube and were switched on/off individually. After obtaining the
inside-out patches, the recording pipette was inserted into the
perfusion tube to achieve a rapid and complete exchange of
solution.
Patch-clamp recordings were performed with the Axopatch
200A ampliﬁer (Axon Instruments). Macroscopic currents were
evoked from a holding potential of 
 
 
 
80 mV every 6 s by a 500-ms
depolarization to a voltage that opens 
 
 
 
70% of the channels (0
to 40 mV, depending on the channel type). To examine the volt-
age dependence of activation, currents were evoked from a hold-
ing potential of 
 
 
 
80 mV every 3 s by 10-ms test potentials from
 
 
 
30 to 
 
 
 
100 mV in 10-mV increments, followed by a 50-ms repo-
larization to 
 
 
 
30 mV. Activation curves were constructed by plot-
ting the tail currents at 
 
 
 
30 mV against the test potentials. Rever-
sal potential was interpolated from current–voltage curves. All
currents were ﬁltered at 2 kHz, digitized at 10 kHz. Data acquisi-
tion and analysis were performed using pClamp8 (Axon Instru-
ments) on a PC through a Digidata 1200 interface. Experiments
were performed at 21–23
 
 
 
C.
MTS reagents (Toronto Research Chemicals) and qBBr (Mo-
lecular Probes) were stored at 
 
 
 
20
 
 
 
C and were dissolved in the
control solution before each experiment, generally 
 
 
 
5 min be-
fore application. 4 mM MTS reagents and qBBr were applied for
2–8 min, until modiﬁcation reached a steady state or the speed of
modiﬁcation could not be distinguished from that of intrinsic
current rundown. The effect of a reagent was calculated from the
current amplitude obtained before application and after washout
of the reagents. Data are represented as mean 
 
 
 
 SD (number of
observations). Signiﬁcance was determined using the Mann-Whit-
ney Test. No corrections were made for leakage current, which
was negligible at 
 
 
 
80 to 100 mV in macropatch recordings. 
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RESULTS
 
Controlling Rundown of P/Q-type Channels
 
The activity of P/Q-type channels is stable in cell-
attached patches, but decreases rapidly and disappears
eventually when a membrane patch is excised into the
inside-out conﬁguration. The speed of this rundown is
relatively constant among the same batch of oocytes
but varies from batch to batch. To examine cysteine
modiﬁcation by an internal reagent, we ﬁrst needed to
prevent or slow down channel rundown. Our previous
work indicates that this can be accomplished by perfus-
ing the membrane with a bath solution containing Mg-
ATP (2 mM) and a low concentration (3 
 
 
 
M) of PIP
 
2
 
immediately after patch excision (Wu et al., 2002).
With such a treatment, the remaining current obtained
10 min after patch excision increased from 34.1% (nor-
malized by the current measured immediately after
patch excision) in the bath solution to 85.6% (
 
n
 
 
 
  
 
6).
This reduced rundown permitted us to carry out the
cysteine modiﬁcation experiments.
 
Construction of a Control Channel Nonreactive to 
Sulfhydryl-speciﬁc Modifying Reagents
 
Another prerequisite for using SCAM is the ability
to clearly distinguish the response of the cysteine mu-
tant channels from that of the wild-type channel. The
Ca
 
v
 
2.1 subunit used in our experiments contains 28 en-
dogenous cysteines, out of which nine are in the extra-
cellular and intracellular loops, respectively, nine in the
transmembrane segments, and one in the P-loop. De-
spite the presence of nine extracellular cysteines, exter-
nal MTS reagents did not produce signiﬁcant irrevers-
ible current inhibition in the wild-type channel (un-
published data). Similar lack of effect by extracellular
sulfhydryl modiﬁers was also observed in the cardiac
L-type Ca
 
2
 
 
 
 channel (Wu et al., 2000). On the other
hand, the wild-type P/Q-type channel was irreversibly
and completely inhibited by internal MTSEA or MT-
SET (Fig. 1, B and C), indicating that one or more en-
dogenous cysteines were covalently modiﬁed. To elimi-
nate the intrinsic reactivity with internal modiﬁers, we
substituted alanine for eight endogenous cysteines in
the NH
 
2
 
 terminus (C71), intracellular loops (C1246,
C1378, and C1543), COOH terminus (C1877, C2088,
and C2123), and IVS6 (C1807) in the 
 
 
 
1
 
 subunit (Fig. 1
A). The channel formed by this mutant 
 
 
 
1
 
 subunit with
 
 
 
2
 
 
 
 and 
 
 
 
 subunits was called “the control channel.” It
was functional and generated large macroscopic cur-
rents in oocytes, the amplitude of which was compara-
ble to that produced by wild-type channels. The activa-
tion voltage of the control channel was shifted by 
 
 
 
20
mV but the speed of inactivation was little affected (Ta-
ble I). Importantly, the control channel did not show
signiﬁcant reactivity with internal MTSEA or MTSET
Figure 1. Construction of a control channel nonreactive to inter-
nal MTSET. (A) Putative transmembrane topology of the  1 subunit
of a voltage-gated Ca2  channel. Black dots show the location of
the endogenous cysteines that were substituted with alanines. (B
and D) Time course of inhibition of the wild-type channel (B) and
control channel (D) by 4 mM internal MTSET. Current was evoked
from a holding potential of  80 mV every 6 s by a 500-ms depolar-
ization to  30 mV. (C and E) Exemplar current traces of the
wild-type channel (C) and control channel (E) taken immediately
before (a) and after (b) MTSET application and immediately
before (c) and after (d) washout of MTSET, as indicated in B and D.
Figure 2. Amino acid sequences and schematic topology. (A)
Amino acid sequence of S6 and S5 segments in the four repeats of
the Cav2.1 subunit. Amino acid numbers are given on both sides.
The numeration of residues in each repeat deﬁned in this study is
shown on the top and bottom. Position 0 presumably represents
the membrane/cytoplasm interface. (B). Schematic topology of
the S5 and S6 segments and the P-loop of two repeats.196 Architecture of Ca2  Channel Inner Pore
(Fig. 1, D and E), and it was also nonreactive to exter-
nal MTS reagents (not depicted). Furthermore, the ac-
tivity of the control channel could still be stabilized by
Mg-ATP (2 mM)   PIP2 (3  M) in inside-out patches.
S6 Transmembrane Segments Form the Inner Pore
After overcoming the two technical obstacles for using
SCAM, we began to identify residues that may form the
inner pore, focusing on the S6 segments of the  1 sub-
unit. We aligned the amino acid sequence of all four S6
segments based on a conserved asparagine (Fig. 2 A,
top). The putative residue at the interface of the mem-
brane and cytoplasm is deﬁned as position 0. Residues
in the membrane are numbered as 1, 2, 3, etc., from in-
side to outside, and residues beyond the membrane are
numbered as  1,  2,  3, etc. To determine putative
pore-lining residues, we replaced, one by one, a total of
87 consecutive residues in all four S6 segments with a
cysteine, mainly from position 14 to position  3 in
each repeat. All but ﬁve mutant  1 subunits formed
functional channels in oocyte. The ﬁve mutants that
failed to produce large enough Ba2  currents are IS6-
N8C, IIIS6-Y18C, IIIS6-V20C, IVS6-L7C and IVS6-N8C.
The effect of internal MTSET on currents mediated
by the S6 cysteine mutant channels is summarized in
Fig. 3. Some mutant channels did not show signiﬁcant
functional change after exposure to MTSET (as exem-
pliﬁed in Fig. 4 A), suggesting that these residues do
not line the pore. Many mutant channels, however,
showed varying degrees of irreversible inhibition (as
exempliﬁed in Fig. 4, B and C). The side chain of these
residues is presumably exposed to the aqueous pore.
Among the eight IIIS6 NH2 terminus residues (from
IIIS6-15 to IIIS6-25 except for two nonfunctional chan-
nels and one mutant whose DNA was not constructed
due to some technical problems), only one (IIIS6-
F22C) was partially modiﬁed by MTSET, suggesting
that this part of the S6 might be buried behind the se-
lectivity ﬁlter and pore helix, as it is in K  channels.
When the results are represented in an  -helical wheel
(Fig. 5), most of the MTSET-reactive positions are lo-
cated on one side of the S6 helices, supporting the in-
terpretation that they face the lumen of the pore.
These results indicate that the S6 segments form the
Ca2  channel inner pore. Notice, however, that the re-
active side is broader than the nonreactive side and
some reactive positions are located on the back side of
the helical wheel. These results will be discussed later.
Many of the residues that are presumably at or below
the membrane boundary (position 0 to position  3 in
TABLE I
Summary of the Effect of MTSET on IS6 Cysteine Mutant Channels
Positions in IS6 MTSET inhibition Reversal potential Activation V1/2 Slope factor k   at 0 mV
Inactivation before 
modification
Inactivation after 
modification
%m V m V m V m s %%
WT 100.0   0.0 (6) 84.4   2.8 26.0   2.6 8.6   1.3 4.4   2.0a 9.5   3.9
Control 19.0   5.9 (20) 82.7   4.8 6.6   3.6 9.0   0.9 5.4   2.2 8.1   4.2 14.5   4.4
G347C 14 23.2   7.6 (6) 73.2   13.0 3.4   6.9 10.6   1.1 3.2   1.0 14.2   5.6 19.9   19.3
S348C 13 45.1   11.0 (4) 81.1   6.9 1.5   5.8 8.1   1.0 6.7   1.1 32.3   13.5 46.1   15.2
F349C 12 37.5   9.5 (4) 83.3   4.8 12.3   8.3 12.2   2.6 8.2   8.8 30.1   15.4 41.9   19.1
F350C 11 25.6   10.5 (6) 74.8   8.8  0.3   6.1 10.7   1.7 4.0   1.8 14.1   9.5 27.1   21.9
M351C 10 15.3   6.4 (3) 84.0   5.0 6.1   2.9 9.6   0.6 8.0   2.3 8.5   7.8 15.5   15.3
L352C 9 57.2   8.3 (5) 82.2   3.3 16.8   7.1 13.6   0.9 3.4   0.9 50.3   8.3 60.6   5.0
L354C 7 28.2   8.1 (3) 72.7   10.1 33.5   2.5 21.7   2.6 1.6   0.6 28.1   13.3 40.1   28.3
V355C 6 18.1   10.4 (4) 78.3   10.7 5.6   9.4 8.3   1.6 8.4   6.3 19.5   17.0 26.5   20.2
L356C 5 81.2   4.0 (4) 71.5   10.3 1.4   5.8 9.4   1.1 5.9   1.8 5.1   3.8 7.7   2.7
G357C 4 86.8   3.7 (3) 68.5   2.1 87.6   1.7 15.1   1.5 1.7   0.2 51.1   5.5 22.0   4.6
V358C 3 15.3   3.7 (7) 74.1   6.6  2.1   10.8 8.7   3.2 4.0   1.4 10.1   16.6 14.7   19.6
L359C 2 67.7   2.9 (4) 76.8   3.0  5.9   3.9 8.8   1.4 5.2   2.8 16.7   7.3 36.3   6.3
S360C 1 86.4   7.4 (5) 84.4   1.7 28.5   3.3 15.6   0.7 3.5   1.1 41.3   20.7 76.2   8.8
G361C 0 46.9   4.0 (5) 68.4   3.8  3.9   4.7 8.7   2.1 2.8   1.6 16.8   6.4 10.5   3.4
E362C  1 9.2   6.5 (5) 82.4   4.5 19.9   1.7 12.5   0.6 3.0   1.2 25.6   7.7 40.8   3.7
F363C  2 98.8   1.2 (5) 77.8   6.5  10.8   7.2 10.4   3.3 3.1   2.7 37.7   15.5
A364C  3 40.2   5.6 (8) 77.5   5.8  3.8   3.6 8.7   0.8 3.8   1.4 13.2   4.4 35.9   6.6
Summary of the effect of MTSET on the S6 cysteine mutant channels in all four repeats. Also included are some of the activation and inactivation properties
of the mutant channels. The data for the reversal potential, half-activation voltage (V1/2), slope factor (k) and time constant ( ) of activation at 0 mV were
obtained from the cell-attached configuration. Inactivation was calculated as the ratio of the current decrease and the peak current during the 500-ms
depolarization. Inactivation was not determined for some mutant channels due to the small residual current after MTSET modification.
aTime constant of activation at  20 mV was calculated for the wild-type channel because open probability of the channel is very low at 0 mV.Zhen et al. 197
each repeat), also showed different degrees of modiﬁ-
cation, and modiﬁcation of one position, IIS6-N-1C,
showed a current increase of 55.6   16.5% (n   7)
(Fig. 3). Since MTSET could reach these positions
from all directions around the presumed helices, modi-
ﬁcation of these residues does not necessarily mean
that they face the ion conduction pathway. It is possible
that the effect of MTSET on at least some of these mu-
tant channels, especially the augmentation of IIS6-N-1C,
is an allosteric effect.
To determine whether the functional effect of MT-
SET on the S6 mutants is due to a change of gating, we
examined the voltage dependence of activation before
and after MTSET application for four mutant channels,
one in each repeat (IS6-L2C, IIS6-N-1C, IIIS6-A4C, and
IVS6-V5C). The activation curves of these channels were
not signiﬁcantly altered after modiﬁcation, as exempli-
ﬁed in Fig. 6. Thus, covalent modiﬁcation by MTSET
most likely inhibits these mutant channels by blocking
the ion conduction pathway rather than by changing
channel gating. However, MTSET may inhibit currents
by different mechanisms at different positions, either by
blocking ion conduction or changing gating, or both.
Some Positions in the S5 Segments Are Accessible
As mentioned above, the MTSET-reactive surface of all
four S6 segments is broad (Fig. 5). In IIS6, ﬁve consecu-
tive positions showed clear modiﬁcation (Fig. 3). Fur-
thermore, some reactive positions are located on the
back side of the helical wheel (Fig. 5). This pattern of
Figure 5. Helical wheel representation of MTSET modiﬁcation of
S6 positions. The effect of internal MTSET on the cysteine mutant
channels (position 1–14) for each S6 segment is shown in an
 -helix wheel. Filled circles indicate positions that were modiﬁed
by MTSET and open circles indicate those that were not modiﬁed.
Cysteine mutant channels that had no function are shown in little
black dots.
Figure 3. Summary of the effect of MTSET on S6 mutant
channels. Bars represent current inhibition by 4 mM internal
MTSET on the control channel (n   20) and S6 cysteine mutant
channels (n   3–15). Stars indicate mutant channels that were
signiﬁcantly inhibited compared with the control channel (P  
0.05). Circles and triangles indicate, respectively, positions that
were either not mutated or mutated but failed to produce
functional channels. Original data are summarized in Tables I IV.
Experiment conditions were the same as in Fig. 4 A.
Figure 4. Examples of different effects of
MTSET on cysteine mutant channels. (A)
Time course of little inhibition of IS6-V3C by
internal MTSET. 4 mM MTSET was applied
continuously for 2 min. Current was evoked
from a holding potential of  80 mV every 6 s
by a 500-ms depolarization to a voltage that
gives  70% channel open probability. (B and
C) Time course of partial inhibition of
IIIS6-P13C (B) and complete inhibition of
IIS6-V1C (C) by internal MTSET. Experiment
conditions were the same as in A.198 Architecture of Ca2  Channel Inner Pore
accessibility does not ﬁt any known sequence alignment
with K  channels and suggests the existence of an aque-
ous pathway for MTSET behind S6. If this were the
case, one would expect that some positions on the S5
segments, which are likely to be immediately adjacent
to and surround the S6 segments as in K  channels,
would be accessible to internal MTSET. To test this pos-
sibility, we substituted all IIIS5 residues and eight resi-
dues at the intracellular end of IIS5 and IVS5 with cys-
teines and examined their accessibility to internal MT-
SET. Because there is no reactive position on the back
side of IS6 (Fig. 5), we decided not to test IS5.
In IIS5 and IVS5 segments, the ﬁrst position, which
presumably lies at the membrane/cytoplasm interface,
was reactive to internal MTSET. More important, posi-
tion 6 in IIIS5 and positions 3 and 8 in IVS5, which are
located deep in the membrane, also showed apparent
modiﬁcation (Fig. 7). The current inhibition caused by
MTSET was small, but nevertheless, it was signiﬁcant.
Since MTSET is permanently charged and does not
partition into the membrane, modiﬁcation of these S5
positions suggests that either some portions of S5 con-
tribute to form the inner pore or there is an aqueous
crevice between S5 and S6. The latter seems more likely
since in K  channels the S5 segments are clearly be-
hind the pore. If this is indeed the case, the current in-
hibition caused by MTSET modiﬁcation is then an al-
losteric effect rather than a direct block of the pore.
The Inner Pore Can Open to 10 Å
In our experiments, by introducing a single cysteine
into an S6 segment, only one MTSET moiety is at-
tached to an accessible cysteine. It was thus surprising
that some S6 mutant channels were almost completely
inhibited by MTSET (e.g., IIS6-A4C, IIIS6-V9C, Fig. 3).
Does this mean that the inner pore at those regions is
as narrow as 5.8 Å in diameter, which is the dimension
of the MTSET head group? To explore the dimension
of the inner pore, we tested modiﬁcation of selected S6
cysteines by another positively charged sulfhydryl-spe-
ciﬁc reagent qBBr, which is rigid and has a dimension
of 12 Å   10 Å   6 Å. qBBr produced a clear and large
inhibition of IIS6-A4C and IIIS6-V9C channels (Fig. 8),
although the speed of modiﬁcation was much slower
than that by MTSET. Considering the rigidity of qBBr,
the inner pore must open to at least 10 Å to accommo-
date this molecule.
DISCUSSION
Knowledge of the structure of the inner pore is impor-
tant for understanding the mechanisms of ion perme-
ation, drug binding, and gating. In this study, we inves-
tigated the architecture of the inner pore of VGCCs
using site-directed chemical modiﬁcation. Our results
reveal that the S6 transmembrane segments form a
Figure 7. Summary of the effect of MTSET on S5 mutant
channels. Bars represent current inhibition by 4 mM internal
MTSET on S5 cysteine mutant channels (n   3–8). Stars indicate
the mutant channels that were signiﬁcantly inhibited compared
with the control channel (P   0.05). Mutants bearing the cysteine
mutation in positions 5 and 13 in IIIS5 failed to produce func-
tional channels.
Figure 8. Effect of qBBr on the control channel and two S6
mutant channels. (A) Time course of inhibition of IIIS6-V9C by
4 mM internal qBBr. (B) Bars represent current inhibition of
the control and mutant channels by 4 mM qBBr applied to the
intracellular side for 8 min. Steady-state inhibition was not reached
due to the slow modiﬁcation.
Figure 6. Gating is not changed after modiﬁcation by MTSET.
(A) Time course of inhibition of a representative mutant channel,
IS6-L2C, by 4 mM internal MTSET. (B) Voltage dependence of
activation of IS6-L2C before (ﬁlled circle) and after (open circle)
MTSET application (n   6).Zhen et al. 199
wide inner pore, which has some unique and unex-
pected properties.
Pore-lining vs. Nonpore-lining Residues
A key assumption in using SCAM to identify pore-lining
residues is that the cysteine mutation by itself does not
alter the side-chain orientation of the substituted resi-
due and the overall structure of the channel. This as-
sumption is difﬁcult to verify directly, but the fact that
the functional properties of many mutant channels
were not signiﬁcantly altered by the cysteine mutation
(Tables I–IV) suggests that it holds true for those chan-
nels. However, many other mutant channels (such as
L354C, N707C, I712C, N1513C, and I1514C, to give a
few examples) did show signiﬁcant changes in their ac-
tivation and/or inactivation properties (Tables I–IV).
Some of the changes were probably caused by the
highly variable contamination from the Cl  current
mediated by the endogenous Ca2 -activated Cl  chan-
nels, which can also be activated to a lesser degree
by Ba2 , the charge carrier used in our experiments.
Other changes could be genuine since the S6 segments
are intimately involved in both activation (Xie et al.,
2005) and inactivation gating in VGCCs (for review see
Hering et al., 2000; Stotz and Zamponi, 2001). For
these mutant channels, we can only hope that the
aforementioned assumption also holds true. This hope,
however, is not a completely blind one since in K 
channels, where many S6/M2 cysteine mutations also
greatly altered various channel properties, the putative
pore-lining residues identiﬁed by SCAM match nicely
those revealed directly by x-ray crystallography (Liu et
al., 1997; Doyle et al., 1998; Lu et al., 1999a; Kuo et al.,
2003), suggesting that the assumption does hold in K 
channels.
Another key assumption is that when a mutant chan-
nel is inhibited by internal MTSET, the corresponding
cysteine, and by inference, the original residue, points
its side chain to the pore or to an aqueous crevice that
is continuous with the pore or the cytoplasm; on the
other hand, when a mutant channel is unaffected by in-
ternal MTSET, the corresponding residue points its
side chain to the membrane or the protein interior.
This is a reasonable proposition for S6 residues located
within the membrane since MTSET is permanently
charged and does not partition into the membrane
(Karlin and Akabas, 1998). Although there is a theoret-
ical possibility that modiﬁcation of a pore-lining resi-
due may be functionally silent, our observation that
most of the MTSET-reactive positions form a broad and
continuous surface (Fig. 5) makes this possibility seem
unlikely.
In this study, accessibility was determined by the
change in current amplitude after exposure to MTSET.
There are caveats to this approach, particularly for
those mutant channels that showed only partial current
TABLE II
Summary of the Effect of MTSET on IIS6 Cysteine Mutant Channels
Positions in IIS6 MTSET inhibition Reversal potential Activation V1/2 Slope factor k   at 0 mV 
Inactivation before 
modification
Inactivation after 
modification
%m V m V m V m s %%
WT 100.0   0.0 (6) 84.4   2.8 26.0   2.6 8.6   1.3 4.4   2.0a 9.5   3.9
Control 19.0   5.9 (20) 82.7   4.8 6.6   3.6 9.0   0.9 5.4   2.2 8.1   4.2 14.5   4.4
G701C 14 11.2   7.2 (5) 76.2   4.8  17.6   2.8 7.3   0.6 2.8   0.4 2.6   2.3 3.4   2.3
N702C 13 43.0   5.5 (7) 82.0   4.5  1.1   6.3 8.9   1.5 4.2   0.9 24.4   13.6 25.9   6.8
Y703C 12 41.9   12.4 (9) 82.0   3.4 17.0   3.6 11.7   1.2 3.4   1.2 48.4   15.7 54.6   18.6
T704C 11 28.4   9.2 (11) 82.5   4.1 7.6   3.6 10.1   0.7 5.0   2.1 16.8   10.4 30.4   16.8
L705C 10 85.8   2.6 (4) 75.8   8.3  6.0   1.6 6.9   0.6 5.6   1.0 28.0   10.4
L706C 9 55.5   8.3 (5) 83.4   2.4 19.8   2.2 12.8   0.6 2.8   0.6 25.2   8.8 39.2   4.9
N707C 8 56.2   2.4 (4) 83.0   0.8 5.0   3.8 9.0   1.6 6.6   2.9 74.5   10.4 90.5   6.8
V708C 7 16.6   2.8 (4) 67.3   8.4  12.1   4.4 8.9   0.8 2.4   1.2 3.1   2.5 2.4   4.2
F709C 6 20.1   2.3 (5) 64.2   7.6  14.3   7.8 7.2   3.5 3.9   2.1 2.3   1.9 2.7   3.2
L710C 5 87.7   2.3 (3) 65.0   7.1  10.1   4.6 8.7   0.3 4.9   1.2 5.8   3.3
A711C 4 99.2   1.2 (4) 86.8   2.8  2.1   4.0 7.0   1.6 6.4   2.5 28.9   10.9
I712C 3 35.6   3.9 (7) 60.0   19.6  22.8   9.8 8.8   1.2 2.9   1.4 2.2   1.7 1.2   2.7
A713C 2 78.7   4.1 (4) 77.8   1.3  5.6   5.0 6.9   1.1 2.6   1.0 7.2   4.7 16.8   3.5
V714C 1 100.0   0.0 (3) 83.3   0.6 1.3   5.1 8.6   0.8 10.3   8.0 11.6   3.2
D715C 0 77.3   4.8 (4) 74.3   6.1 6.2   3.2 9.8   1.3 5.7   3.8 17.9   5.9 8.8   2.1
N716C  1  55.6   16.5 (7) 70.4   3.5 8.6   3.6 11.6   1.8 2.7   0.6 22.3   9.8 15.3   4.6
L717C  2 9.6   11.5 (5) 82.2   5.4 8.9   3.7 14.4   2.0 2.5   0.4 15.7   5.5 21.2   5.7
A718C  3 61.2   7.6 (5) 77.8   8.7  0.9   3.3 9.5   0.2 2.9   0.4 15.9   5.5 20.8   5.0
aSame as in Table I.200 Architecture of Ca2  Channel Inner Pore
inhibition (Fig. 3). The partial inhibition itself is not
surprising, since only a single cysteine in one of the
four pore-lining segments was modiﬁed. In K  chan-
nels, modiﬁcation of a single cysteine in one of the four
subunits also produces only 10–25% inhibition (Lu et
al., 1999a; Loussouarn et al., 2001). The partial inhibi-
tion we observed in this study could not be attributed
to channel rundown since we could clearly and easily
separate the two processes (e.g., Fig. 4 B). But could it
be a nonspeciﬁc effect, at least for those mutant chan-
nels where an extended period of time (up to 4 min) of
MTSET exposure was required to achieve steady-state
inhibition? We cannot exclude this possibility, but two
reasons argue against it. First, in each S6 segment, most
of the reactive positions form a continuous face, bor-
dered by positions 4 and 13 (Fig. 5), rather than dot
randomly, as would be expected if modiﬁcation oc-
curred at random as a result of spontaneous dynamic
conformational changes of the channel protein. Sec-
ond, in our previous work on Kir2.1 channels, we also
observed several positions that were modiﬁed partially
and slowly (Lu et al., 1999a). Those positions corre-
spond to pore-lining positions in the KcsA and MthK
crystal structure (Doyle et al., 1998; Jiang et al., 2002b).
Ca2  Channel Inner Pore Is Asymmetric
The inner pore of K  channels is formed by the S6/M2
segments from four identical subunits. The inner pore
of VGCCs, on the other hand, is formed by the S6 seg-
ments from four homologous but nonidentical repeats.
Thus, there is an intrinsic amino acid sequence asym-
metry to the Ca2  pore. This asymmetry is also demon-
strated by the differential functional impact of MTSET
modiﬁcation. For instance, position 10 was modiﬁed in
both IIS6 and IVS6, but the resulting current inhibition
was dramatically different (85.8   2.6% vs. 31.4  
8.8%); furthermore, the same position was not modi-
ﬁed in IS6 and IIIS6 (Fig. 3). Another example is that
positions 1 and 2 were modiﬁed in every repeat; how-
ever, the current inhibition was  100% and  70% in
TABLE III
Summary of the Effect of MTSET on IIIS6 Cysteine Mutant Channels
Positions in IIIS6 MTSET inhibition Reversal potential Activation V1/2 Slope factor k   at 0 mV
Inactivation before 
modification
Inactivation after 
modification
%m V m V m V m s %%
WT 100.0   0.0 (6) 84.4   2.8 26.0   2.6 8.6   1.3 4.4   2.0a 9.5   3.9
Control 19.0   5.9 (20) 82.7   4.8 6.6   3.6 9.0   0.9 5.4   2.2 8.1   4.2 14.5   4.4
M1496C 25 18.0   5.9 (10) 82.1   3.2 3.7   3.0 9.9   0.6 3.3   0.9 10.1   4.5 21.3   11.0
I1498C 23 24.4   4.1 (10) 81.2   4.5 8.2   4.0 10.6   0.9 4.6   2.8 14.5   9.2 28.8   13.8
F1499C 22 28.9   7.8 (13) 80.1   5.7 12.6   3.8 11.6   1.5 3.5   0.7 12.9   8.0 25.7   13.9
Y1500C 21 24.6   7.8 (7) 72.0   4.9 3.8   4.7 11.5   1.0 4.0   2.7 11.2   7.5 11.7   4.9
V1502C 19 24.3   7.9 (8) 80.0   5.4 8.2   2.7 10.4   1.5 4.3   1.1 13.9   5.8 28.8   8.8
F1504C 17 13.8   8.1 (4) 82.3   0.5 10.2   2.7 10.5   0.3 8.2   3.8 9.0   1.9 16.6   1.2
V1505C 16 17.3   11.2 (5) 82.1   3.4 12.1   3.9 9.5   0.7 5.2   1.2 11.2   4.0 16.8   4.1
V1506C 15 22.4   4.9 (12) 78.2   6.4 1.6   3.9 10.1   0.9 2.7   0.9 11.2   6.3 23.3   12.9
F1507C 14 22.6   5.9 (5) 82.3   3.1 6.0   1.7 9.9   0.6 4.1   0.4 15.2   7.8 33.8   5.7
P1508C 13 39.0   9.7 (9) 81.9   3.9 7.1   5.3 13.8   2.5 2.9   0.6 19.2   8.2 25.8   11.9
F1509C 12 33.2   11.9 (12) 80.6   6.0 12.8   5.5 11.0   2.8 4.8   2.6 26.7   15.6 40.0   17.8
F1510C 11 27.0   11.9 (15) 79.5   5.1 6.8   4.7 8.6   1.0 5.2   4.9 20.7   12.0 30.2   18.1
F1511C 10 17.7   6.5 (4) 73.3   10.9  5.7   4.1 8.2   1.6 4.0   2.4 15.7   10.0 24.1   12.6
V1512C 9 93.0   1.6 (4) 73.7   6.1 1.8   4.8 8.0   0.5 5.2   4.3 25.8   6.7 52.2   10.6
N1513C 8 42.0   6.4 (4) 86.0   1.6 1.7   1.9 8.7   1.8 4.3   0.7 86.0   7.4 96.1   4.5
I1514C 7 39.8   6.1 (5) 75.6   18.0 41.1   13.1 15.9   1.0 1.7   0.2 19.9   8.9 25.0   12.3
F1515C 6 13.1   2.7 (5) 80.2   5.1  6.0   4.2 9.2   0.9 2.9   1.1 11.2   3.6 12.9   3.8
V1516C 5 43.6   9.2 (4) 69.5   19.1 8.5   5.4 10.4   1.6 5.4   0.1 5.8   4.0 7.9   6.9
A1517C 4 73.6   10.0 (5) 75.6   10.3  9.8   7.1 6.8   0.7 6.0   1.9 16.0   3.5 15.7   10.6
L1518C 3 24.0   3.6 (6) 82.7   3.4 18.9   7.3 16.2   4.4 2.1   0.6 30.3   17.9 27.4   16.2
I1519C 2 35.1   10.8 (8) 81.6   5.1  2.4   5.4 7.6   1.2 5.7   2.2 20.0   8.4 38.4   16.8
I1520C 1 52.6   4.1 (4) 60.0   13.1  7.5   3.7 6.9   1.1 3.9   2.0 7.8   9.3 11.3   15.7
I1521C 0 30.3   4.0 (4) 74.0   2.2 10.0   1.9 11.1   0.5 6.8   2.3 54.3   13.1 16.2   10.1
T1522C  1 45.3   7.0 (7) 72.9   3.7  9.0   7.1 12.3   1.9 2.3   0.6 35.8   7.6 14.3   7.2
F1523C  2 35.5   7.4 (4) 75.5   3.9  6.2   3.1 9.3   1.0 1.9   0.5 13.9   3.3 23.3   4.5
Q1524C  3 42.4   4.0 (4) 85.8   2.5 9.0   4.8 7.8   1.0 5.2   1.9 10.2   3.7 17.4   4.6
aSame as in Table I.Zhen et al. 201
IS6, IIS6, and IVS6, but only 52.6   4.1% and 35.1  
10.8% in IIIS6 (Fig. 3). These results lend support to
the notion that the four S6 segments of VGCCs are
functionally nonequivalent, as has been demonstrated
by their differential role in the binding of DHPs, PAAs,
and BTZs (see below for more discussion). They also
suggest that the vertical position and/or orientation of
the four S6 segments may be different.
S6 and S5 Transmembrane Segments May Be Loosely 
Packed
Based on various amino acid sequence alignments, sev-
eral homology models of the inner pore of VGCCs have
been proposed using the crystal structure of KcsA K 
channel as a template (Huber et al., 2000; Zhorov et al.,
2001; Lipkind and Fozzard, 2003). The modiﬁcation
pattern of the S6 segments of VGCCs obtained in this
study does not ﬁt any of the current homology models
and is strikingly different from that of K  channels (Liu
et al., 1997; Lu et al., 1999a). One major difference is
that many more positions above the putative mem-
brane/cytoplasm interface are reactive to MTSET in
Ca2  channels than in K  channels (Fig. 5). Another
major difference is that in IIS6, IIIS6, and IVS6 of Ca2 
channels, one or two positions on the opposite or back
side of the accessible surface, which most likely forms
the lining of the inner pore, are also modiﬁed by inter-
nal MTSET. This observation suggests that either these
S6 segments are not a continuous  -helix, which seems
unlikely based on secondary structure predictions and
the structure of the K  channel S6/M2 segments, or
the pore-lining S6 and surrounding S5 segments are
loosely packed, creating an aqueous crevice in be-
tween. Consistent with the latter hypothesis, several po-
sitions in the S5 segments, some of which are buried
deep in the membrane, were found to react with inter-
nal MTSET (Fig. 7). The current inhibition caused by
modiﬁcation of these positions is most likely an allo-
steric effect instead of a direct pore block. It is possible
that some other S5 positions were also modiﬁed, but
their modiﬁcation was functionally mute.
This type of loose packing between the S5 and S6
transmembrane segments is not present in K  chan-
nels. Our previous study on Kir2.1 channels found that
none of the M1 positions were modiﬁed by either MT-
SET or MTSEA, even after long exposure to high
concentrations of the modifying reagents (Lu et al.,
1999a). More important, the crystal structures of KcsA,
MthK, and KvAP all show that M1/S5 is buried in mem-
brane lipids and is positioned immediately behind the
TABLE IV
Summary of the Effect of MTSET on IVS6 Cysteine Mutant Channels
Positions in IVS6 MTSET inhibition Reversal potential Activation V1/2 Slope factor k   at 0 mV
Inactivation before 
modification
Inactivation after 
modification
%m V m V m V m s %%
WT 100.0   0.0 (6) 84.4   2.8 26.0   2.6 8.6   1.3 4.4   2.0a 9.5   3.9
Control 19.0   5.9 (20) 82.7   4.8 6.6   3.6 9.0   0.9 5.4   2.2 8.1   4.2 14.5   4.4
S1802C 19 33.8   3.1 (5) 82.0   4.6 5.5   3.2 9.3   0.6 3.4   0.6 12.1   3.0 27.9   3.3
F1803C 18 27.3   9.8 (9) 78.0   6.7 11.2   5.5 9.3   1.0 7.7   4.0 20.8   7.3 35.1   12.2
I1804C 17 22.2   2.6 (4) 77.8   4.3 6.9   4.8 10.5   0.7 3.9   0.3 13.5   5.9 19.9   7.0
F1805C 16 27.7   13.9 (12) 83.5   4.5 3.6   2.4 8.7   0.8 6.3   3.6 18.6   8.8 39.7   13.1
L1806C 15 21.1   6.8 (11) 81.9   3.0 7.4   4.2 9.7   1.2 3.3   1.2 16.3   6.9 26.7   12.4
C1807C 14 26.5   14.4 (7) 78.4   7.9 13.6   2.9 11.8   2.0 4.2   1.7 25.5   15.1 37.6   16.1
S1808C 13 65.5   9.0 (7) 78.1   3.9 14.8   4.5 12.6   1.2 5.3   3.1 15.0   5.9 31.6   12.5
F1809C 12 44.1   8.5 (9) 77.0   6.3 3.4   2.6 9.9   0.8 4.9   2.8 13.6   6.9 17.3   10.4
L1810C 11 20.5   1.8 (3) 69.3   3.1 4.2   3.5 10.6   1.1 2.6   0.5 14.3   3.5 25.7   2.5
M1811C 10 31.4   8.8 (8) 84.0   2.7 21.4   4.8 13.5   2.0 3.2   0.7 21.8   10.5 34.6   8.3
L1812C 9 56.5   12.7 (5) 80.4   5.1 14.5   4.2 14.0   3.8 4.2   1.5 34.4   13.9 54.2   11.1
F1815C 6 21.5   9.7 (11) 78.5   6.7 10.4   4.1 11.6   1.6 4.1   1.8 17.2   11.1 34.7   23.5
V1816C 5 59.4   5.4 (5) 82.0   2.8 4.6   2.4 9.3   0.8 4.7   2.3 28.6   9.1 50.5   11.0
A1817C 4 100.0   0.0 (4) 79.0   8.5 8.1   3.1 10.3   1.0 4.3   1.2 33.9   9.3
V1818C 3 25.0   6.6 (9) 80.2   4.7  6.7   4.7 7.9   1.0 5.3   3.0 6.4   3.1 6.6   4.8
I1819C 2 93.2   6.4 (6) 77.0   3.5 7.9   3.4 11.2   1.1 6.1   3.9 17.2   3.9
M1820C 1 99.7   0.6 (5) 78.2   3.5 8.7   4.6 9.0   0.9 2.9   0.9 54.1   16.3
D1821C 0 77.4   4.0 (6) 81.5   3.7 4.9   2.9 7.2   0.5 4.3   1.2 26.2   3.3 50.8   15.7
N1822C  1 58.0   3.7 (4) 86.3   3.5 10.8   2.0 11.2   0.2 3.5   0.4 26.7   7.9 23.9   20.2
F1823C  2 54.1   9.2 (5) 76.0   4.5 6.9   4.2 8.3   0.8 3.9   1.5 22.8   16.5 24.4   12.0
E1824C  3 53.3   7.8 (5) 77.0   7.4 11.8   6.9 8.2   0.7 7.6   2.5 18.5   7.6 16.2   8.3
aSame as in Table I.202 Architecture of Ca2  Channel Inner Pore
pore-forming M2/S6 (Doyle et al., 1998; Jiang et al.,
2002a, 2003a). There is clearly no aqueous crevice be-
tween M1/S5 and M2/S6 that could accommodate a
molecule as big as MTSET.
Ca2  Channel Inner Pore Is Wide
Our results show that many S6 mutant channels were in-
hibited by MTSET by varying degrees (Fig. 3). It is possi-
ble that for channels that are inhibited partially, the side
chain of the modiﬁed positions points tangentially to
the pore, whereas for those that are inhibited by a rela-
tively large degree ( 80%), their side chain points to
the pore more or less perpendicularly. Interestingly, sev-
eral mutant channels are almost completely inhibited,
despite the fact that each mutant channel contains only
a single modiﬁable cysteine in a particular repeat. This
is strikingly different from what has been observed in
K  channels, where modiﬁcation of cysteines on all four
subunits is required to produce complete inhibition
(Lu et al., 1999a; Loussouarn et al., 2001).
To explain this discrepancy between Ca2  and K 
channels, we ﬁrst need to understand how MTSET
modiﬁcation impedes ion conduction in Ca2  channels.
Is it by electrostatic repulsion or physical obstruction, or
both? To address this question, we examined the effect
of MTSEA on IIIS6-V9C, which was almost completely
inhibited by MTSET. MTSEA also carries a single posi-
tive charge but has a smaller head group ( 3.6 Å in di-
ameter) than MTSET does. However, it inhibited the
current by a similar degree as MTSET did (87.3% and
93.0%, respectively; MTSEA inhibited the control chan-
nel by 16.8%) and the modiﬁcation was faster (unpub-
lished data). This result suggests that electrostatic repul-
sion between the head group of a modifying reagent
and the permeant ions plays a predominant role in
blocking the current ﬂow. The much stronger inhibi-
tion by MTSET in Ca2  channels is because the charge
carrier is a divalent cation (Ba2 ), which naturally leads
to stronger electrostatic repulsion. Another piece of evi-
dence supporting this interpretation is the weaker effect
of MTSET modiﬁcation on monovalent currents in
Ca2  channels. To record a monovalent current, we
used the same solution on both sides of the membrane
patch, with K  as the charge carrier. The K  current of
IIS6-A4C was inhibited by 86.3% (n   6), whereas the
Ba2  current was inhibited by 99.2% (n   4) (Fig. 9).
The residual K  current ( 14%) was not mediated by
endogenous K  channels, since it was substantially
larger than the endogenous K  currents recorded from
oocytes lacking exogenously expressed Ca2  channels
(Fig. 9, compare D and F).
Chemical modiﬁcation and x-ray crystallography indi-
cate that the inner pore of K  channels can open to
 12 Å (Lu et al., 1999a; Jiang et al., 2002b). Previous
work on VGCCs suggests that they may also have a large
inner pore. For example, tetramethylammonium, which
has a diameter of  6 Å, can pass through the channel
(McCleskey and Almers, 1985). Large organic mole-
cules such as PAAs, BTZs, and DHPs are thought to
bind within or close to the ion conduction pathway
(Hockerman et al., 1997b). Our ﬁnding that qBBr can
modify residues deep in the inner pore (Fig. 8) suggests
that the Ca2  channel inner pore can open to  10 Å.
Implications for the Binding of DHPs and PAAs
Our results have important implications for under-
standing the mechanism of the binding and actions of
Figure 9. Inhibition of divalent and monovalent current
by MTSET. (A and B) Time course of inhibition of
monovalent (K ) current (A) and divalent (Ba2 ) cur-
rent (B) of IIS6-A4C by internal MTSET. (C) Bar graph
summarizing the degree of inhibition of monovalent
and divalent current. (D and E) Exemplar monovalent
(D) and divalent current traces (E) during MTSET
inhibition. Monovalent current was evoked from a
holding potential of  100 mV every 6 s by a 500-ms
depolarization to  30 mV. Divalent current was evoked
by the same voltage protocol as in Fig. 1 B. (F) Absence
of endogenous monovalent current from uninjected
oocytes at  30 mV (top traces) and all voltages from
 80 to  60 mV (bottom traces, currents were evoked
from a holding potential of  100 mV every 3 s by 10-ms
depolarizations from  80 to  60 mV in 10-mV incre-
ments, followed by a 50-ms repolarization to  80 mV).
Figure 10. Amino acid sequence alignment of IIIS6 and IVS6 of
Cav2.1 with those of Cav1.2. The bold and underlined residues in
IIIS6 and IVS6 of Cav1.2 represent residues whose mutations affect
the binding of DHPs and PAAs, respectively. Stars indicate MTSET-
reactive residues in Cav2.1.Zhen et al. 203
DHPs, PAAs, and BTZs, drugs that are widely used for
the treatment of cardiovascular diseases. DHPs act on
L-type Ca2  channel as either agonists favoring the
open state or antagonists favoring the inactivated state.
Peptide segments contributing to form the DHP-bind-
ing site have been localized to IIIS6 and IVS6 of the  1
subunit by photoafﬁnity labeling and antibody map-
ping (Nakayama et al., 1991; Striessnig et al., 1991;
Kalasz et al., 1993). Site-directed mutagenesis studies
have identiﬁed single amino acid residues in IIIS6 and
IVS6 whose mutations affected DHP binding (Peterson
et al., 1996, 1997). These residues are believed to form
a high-afﬁnity DHP-binding site. If we align the amino
acid sequence of P/Q-type channels with that of L-type
channels (Fig. 10), 5 out of the 10 homologous DHP-
binding residues were not modiﬁed by MTSET (IIIS6:
F11C, F14C, and F17C; IVS6: F16C and I17C). Only
three of them showed modiﬁcation (IIIS6-V9C; IVS6:
L9C and M10C). The other two cysteine mutant chan-
nels (IIIS6-Y18C and IVS6-N8C) did not produce enough
Ba2  current. DHPs are lipophilic compounds that reach
their receptor site through the membrane and they are
thought to be allosteric modulators (Peterson et al.,
1996, 1997; Hockerman et al., 1997b). Our ﬁnding that
many of the putative DHP-binding residues point away
from the pore is in agreement with the idea that DHPs
affect channel activity allosterically rather than by block-
ing the pore directly.
PAAs are another class of high-afﬁnity L-type channel
blockers. A number of amino acid residues in IIIS6 and
IVS6 have been shown to be important for PAA binding
(Hockerman et al., 1995, 1997a,b), some of which are
also involved in DHP binding. It has been hypothesized
that PAAs and DHPs bind to different faces of IIIS6 and
IVS6 and in some cases to opposite sides of the same
amino acid residues (Hockerman et al., 1997b). While
DHPs affect channel activity allosterically, PAAs block
the pore directly (Hockerman et al., 1995, 1997a,b).
However, among the seven analogous putative PAA-
binding residues in P/Q-type channels, only three
(IIIS6-V5C; IVS6: M10C and S13C) were modiﬁed by
MTSET (Fig. 10). Except for IIIS6-Y18C that did not
produce enough Ba2  current, the other three residues
were not modiﬁed and are therefore unlikely to line
the pore. These results suggest that some of the resi-
dues whose mutations affect PAA block may not partici-
pate directly in PAA binding or part of PAA may inter-
act with hydrophobic residues pointing away from the
pore.
Several models have been proposed for the binding
of DHPs and PAAs to Ca2  channels (Huber et al.,
2000; Zhorov et al., 2001; Lipkind and Fozzard, 2003).
They are all based on the KcsA structure and therefore
need further improvement. Our results provide data
for constructing a more realistic model. In particular,
the proposed loose packing between the S5 and S6
transmembrane segments in VGCCs should be a key
consideration in future modeling. This loose packing
may confer certain ﬂexibility to the S5 and S6 segments
that would permit the creation of a binding pocket suit-
able for bulky molecules such as DHPs, PAAs, and
BTZs.
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